Related Experiment Video

Updated: Jun 8, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells

Minhua Feng1, Bo Huang, Zunguo Du

  • 1Ningbo College of Health Science, Ningbo 315000, China.

Molecular Biology Reports
|October 1, 2010
PubMed

Insights

The Deleted in liver cancer-1 (DLC-1) gene, often lost in cancers, was undetectable in Burkitt

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Deleted in liver cancer-1 (DLC-1) gene expression is frequently down-regulated or deleted in various human cancers.
  • The role of DLC-1 in non-Hodgkin lymphoma (NHL) remains largely unexplored, necessitating investigation into its therapeutic potential.

Purpose of the Study:

  • To investigate the expression of DLC-1 in Burkitt's lymphoma (BL) cell lines.
  • To evaluate the therapeutic potential of DLC-1 as a tumor suppressor in BL.

Main Methods:

  • Examined DLC-1 expression in human BL cell lines (Raji and Daudi) using reverse transcription-PCR.
  • Assessed the impact of DLC-1 restoration on BL cell proliferation, apoptosis, and migration.

Main Results:

  • DLC-1 expression was undetectable in both Raji and Daudi BL cell lines.
  • Restoration of DLC-1 expression significantly inhibited BL cell proliferation and induced apoptosis.
  • Reintroducing DLC-1 expression also significantly reduced BL cell migration.

Conclusions:

  • DLC-1 functions as a tumor suppressor gene in non-Hodgkin lymphoma.
  • DLC-1 represents a potential therapeutic target for Burkitt's lymphoma and potentially other NHL subtypes.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...